ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,568Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 315

$780K Total Retail Price of All Prescriptions

Rank: 26 out of 315

570 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 570 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 570 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 8,486 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LEVOTHYROXINE SODIUM 480 433 1 6
AMLODIPINE BESYLATE 379 342 2 2
SIMVASTATIN 342 316 3 1
ATORVASTATIN CALCIUM 336 282 4 5
LISINOPRIL 285 224 5 3
LOSARTAN POTASSIUM 263 242 6 4
WARFARIN SODIUM 214 156 7 20
ALLOPURINOL 196 136 8 14
METFORMIN HCL 196 179 8 7
LOVASTATIN 186 152 10 8
OMEPRAZOLE 166 116 11 9
HYDROCODONE-ACETAMINOPHEN 159 71 S3 12 19
CARVEDILOL 145 108 13 22
CRESTOR 144 129 14 24
FUROSEMIDE 136 114 15 15
ALENDRONATE SODIUM 135 135 16 12
DONEPEZIL HCL 123 123 17 28
POTASSIUM CHLORIDE 120 82 18 36
GLYBURIDE 119 100 R 19 49
TRIAMTERENE-HCTZ 118 90 20 71
ATENOLOL 104 71 21 11
CLOPIDOGREL 99 76 22 25
JANUVIA 99 99 22 31
LOSARTAN-HYDROCHLOROTHIAZIDE 95 69 24 17
ADVAIR DISKUS 91 73 25 46
PRAVASTATIN SODIUM 91 75 25 10
SYNTHROID 89 85 27 51
TRAMADOL HCL 87 68 28 59
CARISOPRODOL 84 29 R 29 166
DIGOXIN 83 79 30 45
RANITIDINE HCL 81 60 31 42
BENICAR 78 71 32 80
ZOLPIDEM TARTRATE 77 61 33 29
PANTOPRAZOLE SODIUM 77 75 33 35
LANTUS SOLOSTAR 75 40 35 69
BYSTOLIC 74 72 36 73
NAMENDA 72 63 37 38
METOPROLOL TARTRATE 68 63 38 18
GABAPENTIN 64 37 39 37
TAMSULOSIN HCL 64 39 39 21
SPIRONOLACTONE 63 63 41 95
IBUPROFEN 62 28 42 89
PLAVIX 61 50 43 40
CIPROFLOXACIN HCL 57 44 44 58
QUETIAPINE FUMARATE 56 40 45 143
NEXIUM 55 40 46 54
METOPROLOL SUCCINATE 55 55 46 13
CEPHALEXIN 54 31 48 109
DIOVAN 53 53 49 27
ACTONEL 52 51 50 47
BENICAR HCT 52 38 50 126
ENALAPRIL MALEATE 50 50 52 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.